- Info
- Insider Trading
- Financials
- Holders: LYEL, LYEL
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)
CUSIP: 55083R104
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 19,277,111
- Total 13F shares
- 82,534,412
- Share change
- +2,832,559
- Total reported value
- $1,221,509,324
- Price per share
- $14.80
- Number of holders
- 61
- Value change
- +$39,832,274
- Number of buys
- 38
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55083R104:
Top shareholders of LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MWG Management Ltd. |
13F
|
Company |
105%
|
20,329,235
|
$330,147,000 | — | 30 Jun 2021 | |
| Apoletto Ltd |
13F
|
Company |
79%
|
15,167,757
|
$246,324,000 | — | 30 Jun 2021 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
69%
|
13,282,181
|
$215,703,000 | — | 30 Jun 2021 | |
| Alphabet Inc. |
13F
|
Company |
30%
|
5,865,125
|
$95,250,000 | — | 30 Jun 2021 | |
| GSK plc |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
30,253,189
|
$68,977,271 | — | 21 Jun 2021 | |
| SB Management Ltd |
13F
|
Company |
18%
|
3,500,000
|
$56,840,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
13%
|
2,500,000
|
$40,600,000 | — | 30 Jun 2021 | |
| HSG Holding Ltd |
13F
|
Company |
13%
|
2,436,798
|
$39,574,000 | — | 30 Jun 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
12%
|
2,348,965
|
$38,147,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.1%
|
1,749,378
|
$28,410,000 | — | 30 Jun 2021 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
8.5%
|
1,647,882
|
$26,761,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
8.5%
|
1,646,846
|
$26,745,000 | — | 30 Jun 2021 | |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC |
13F
|
Company |
6.8%
|
1,320,000
|
$21,436,800 | — | 30 Jun 2021 | |
| Dragoneer Investment Group, LLC |
13F
|
Company |
5.2%
|
1,000,000
|
$16,240,000 | — | 30 Jun 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
5.1%
|
987,928
|
$16,044,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
3.6%
|
700,000
|
$11,368,000 | — | 30 Jun 2021 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
3.1%
|
588,235
|
$9,553,000 | — | 30 Jun 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.1%
|
588,235
|
$9,553,000 | — | 30 Jun 2021 | |
| Arena Capital Advisors, LLC- CA |
13F
|
Company |
2.8%
|
545,137
|
$8,853,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
2.6%
|
499,559
|
$8,113,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
328,033
|
$5,327,000 | — | 30 Jun 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.3%
|
258,823
|
$4,204,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
247,609
|
$4,021,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
1.3%
|
247,200
|
$4,015,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
202,034
|
$3,281,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1%
|
192,840
|
$3,132,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
174,420
|
$2,832,000 | — | 30 Jun 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.83%
|
160,000
|
$2,598,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.68%
|
131,150
|
$2,130,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.52%
|
100,000
|
$1,624,000 | — | 30 Jun 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.52%
|
100,000
|
$1,624,000 | — | 30 Jun 2021 | |
| Eagle Health Investments LP |
13F
|
Company |
0.52%
|
100,000
|
$1,624,000 | — | 30 Jun 2021 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.52%
|
100,000
|
$1,624,000 | — | 30 Jun 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.44%
|
85,000
|
$1,380,000 | — | 30 Jun 2021 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.44%
|
84,383
|
$1,370,000 | — | 30 Jun 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.45%
|
86,489
|
$1,254,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
64,460
|
$1,046,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.26%
|
50,987
|
$828,000 | — | 30 Jun 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.24%
|
45,505
|
$739,000 | — | 30 Jun 2021 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.22%
|
42,718
|
$691,000 | — | 30 Jun 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.16%
|
30,500
|
$495,000 | — | 30 Jun 2021 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.16%
|
30,446
|
$494,000 | — | 30 Jun 2021 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0.15%
|
28,407
|
$461,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.13%
|
25,000
|
$406,000 | — | 30 Jun 2021 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.13%
|
25,000
|
$406,000 | — | 30 Jun 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.11%
|
20,697
|
$336,000 | — | 30 Jun 2021 | |
| Maven Securities LTD |
13F
|
Company |
0.06%
|
12,195
|
$197,000 | — | 30 Jun 2021 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.06%
|
11,954
|
$194,000 | — | 30 Jun 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
5,807
|
$94,000 | — | 30 Jun 2021 | |
| Rokos Capital Management LLP |
13F
|
Company |
0.03%
|
5,000
|
$81,000 | — | 30 Jun 2021 |
Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q3 2021
As of 30 Sep 2021,
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,534,412 shares.
The largest 10 holders included
MWG Management Ltd., Apoletto Ltd, Foresite Capital Management IV, LLC, Alphabet Inc., PRICE T ROWE ASSOCIATES INC /MD/, SB Management Ltd, SC CHINA HOLDING Ltd, HHLR ADVISORS, LTD., VANGUARD GROUP INC, and Board of Trustees of The Leland Stanford Junior University.
This page lists
61
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
52
Q3 2021 holders
61
Holder diff
9
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.